Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. (Q48464426)
Jump to navigation
Jump to search
scientific article published in March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. |
scientific article published in March 2007 |
Statements
1 reference
Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study. (English)
1 reference
Joseph Biederman
1 reference
Robert L Findling
1 reference
Suma Krishnan
1 reference
Yuxin Zhang
1 reference
James J McGough
1 reference
1 March 2007
1 reference
1 reference
29
1 reference
450-463
1 reference
3
1 reference
Identifiers
1 reference
1 reference